PARP1 inhibitors and uses thereof

Compounds selectively inhibiting PARP1 address the need for improved PARP inhibitors by enhancing cancer treatment efficacy and reducing toxicity in HRD and BRCA1/2 mutation cancers, including multiple cancer types.

AU2023213731B2Pending Publication Date: 2026-07-09XINTHERA INC
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
AU2023213731
Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-10-05
Filing Date
2023-01-26
Publication Date
2026-07-09
Patent Text Reader

Abstract

Described herein are PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • PARP1 inhibitors

    WO2021013735A1

  • Quinoxaline derivatives as Anti-cancer drugs

    WO2021260092A1